Altamira Therapeutics Ltd. sell Vassago1
Summary
This prediction ended on 13.04.23 with a price of €1.21. The SELL prediction by Vassago1 for Altamira Therapeutics Ltd. performed very well with a performance of -47.84%. Vassago1 has 50% into this predictionAltamira Therapeutics Ltd. (WKN A3DWPP) is a biopharmaceutical company primarily focused on the research, development, and commercialization of innovative therapeutics to address the needs of patients suffering from a variety of respiratory and immuno-inflammatory conditions. With a diverse portfolio of treatments and therapies, Altamira aims to deliver cutting-edge solutions to improve the quality of life for these patients. Listed on the stock exchange, the company has shown a commitment to growth and success through strategic partnerships, clinical trials, and an emphasis on research and development. By continuously striving to discover and develop novel therapies, Altamira Therapeutics Ltd. establishes itself as a vital player in the world of biopharmaceuticals with the potential to revolutionize the way respiratory and immuno-inflammatory diseases are treated.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Altamira Therapeutics Ltd. | - | - | - |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to Vassago1 what are the pros and cons of Altamira Therapeutics Ltd. for the foreseeable future?
Pros
Cons
Comments by Vassago1 for this prediction
In the thread Altamira Therapeutics Ltd. diskutieren